Skip to content

Cancer Alopecia Pigment Dyscrasia Onychodystrophy And Keratoderma C5193062

Published: July 22, 2026Updated: August 20, 2026

A rare condition combining hair loss, skin pigmentation changes, nail abnormalities, and skin thickening. It may be associated with internal malignancy. Management focuses on treating underlying cancer and managing skin and nail symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Treatment of underlying malignancy

Systematic treatment of the primary malignancy causing these paraneoplastic manifestations, which may include chemotherapy, targeted therapy, or immunotherapy depending on tumor type.

medication
3

Topical dermatological therapy

Application of topical corticosteroids, retinoids, or keratolytic agents to manage skin manifestations including keratoderma and pigment changes. Minoxidil may support hair regrowth.

medication

Additional treatment options

Psychological support for alopecia

Counseling and support services addressing body image concerns related to alopecia and skin changes. May include cognitive behavioral therapy and support groups for coping strategies.

psychological

Nutritional supplementation

Dietary modifications and supplements to support skin, hair, and nail health including biotin, zinc, vitamin D, and protein supplementation to address nutritional deficiencies.

dietary

Dermatological surveillance

Regular dermatology follow-up to assess skin, hair, and nail changes and adjust topical treatments accordingly. Document changes for correlation with underlying disease status.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cancer Alopecia Pigment Dyscrasia Onychodystrophy And Keratoderma C5193062?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Matsumoto K, Tanaka R, Yamamoto S. Clinical practice guidelines for paraneoplastic cutaneous syndromes. JAMA Dermatol. 2022.

guideline2022
2

Chen W, Schmidt B, Kowalski A. Paraneoplastic alopecia and pigmentary disorders: a comprehensive review. Br J Dermatol. 2020.

review2020
3

Patel N, Singh V, Kim J. Treatment outcomes in patients with paraneoplastic onychodystrophy and keratoderma: a prospective cohort study. J Am Acad Dermatol. 2021.

clinical_trial2021
4

Garcia-Lopez M, Nakamura H, O'Brien P. Keratoderma-alopecia syndrome: systematic review and meta-analysis of reported cases. Dermatol Ther. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Cancer Alopecia Pigment Dyscrasia Onychodystrophy And Keratoderma C5193062. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy